AmpC β-lactamases can interfere with extended-spectrum-β-lactamase (ESBL) confirmatory tests. Resulting failures to detect ESBLs can endanger patients because false susceptibility to cephalosporins may be reported ([5][1]). This problem occurs with CLSI and some other ESBL confirmatory tests, but
No takes yet. Share an insight, caveat, or question.
Munier et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: